SyntheticMR
Markus Malmgren has a diverse and extensive work experience spanning various roles and industries. Markus is currently the Chief Technology Officer at SyntheticMR, a position they assumed in September 2021. Prior to this, Markus was the Head of R&D at SyntheticMR from February 2019 to September 2021.
Before joining SyntheticMR, Markus had a significant tenure at Zenterio, where they held the role of Head of Zenterio Development from November 2015 to February 2019. Markus also served as the Head of Methods & Tools and Outsourcing at Zenterio from January 2014 to November 2015.
Markus has also worked at Enea Software AB, where they worked in various roles including Director Product Line RTOS and Director Product Management & Architecture. Markus was also a Team Manager during their time at Enea Software AB. Prior to that, Markus held Project Management roles at Scania IT AB and ÅF AB.
Additionally, Markus has experience at Autoliv Electronics as a Team Leader and at the Swedish Defence Research Agency as a Software Engineer. Overall, Markus Malmgren's work experience showcases their expertise in technology, R&D, project management, and team leadership.
Markus Malmgren obtained a Master of Science (M.Sc.) degree in Applied Physics and Electrical Engineering from Linköping University from 1999 to 2004.
SyntheticMR
SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI) that supports a faster and more precise diagnosis of patients worldwide. Join us for the latest updates on news, events and clinical research involving our products. SyntheticMR’s unique SyMRI technology measures the absolute properties of the brain and delivers adjustable contrast images, automatic biomarker segmentation and quantitative data in a single fast scan. SyMRI is designed to help you save valuable time by reducing scan time, all the while aiding as an objective decision support for diagnosis and patient follow-ups. SyMRI offers a fast and standardized protocol with clinically relevant quantitative data for more robust assessments of patients. SyntheticMR AB is headquartered in Linköping, Sweden with sales representation in the USA, Japan and India. The company was founded in 2007 and is listed on the AktieTorget exchange in Stockholm, Sweden.